Gestational diabetes mellitus epigenetically affects genes predominantly involved in metabolic diseases
Authors:
- Stephanie-May RuchatSRStephanie-May Ruchat
- Andrée-Anne HoudeAHAndrée-Anne Houde
- Grégory VoisinGVGrégory Voisin
- Patrice PerronPPPatrice Perron
- Jean-Patrice BaillargeonJBJean-Patrice Baillargeon
- Daniel GaudetDGDaniel Gaudet
- Marie-France HivertMHMarie-France Hivert
- Diane BrissonDBDiane Brisson
- Luigi BouchardLBLuigi Bouchard
Open Access
- 1 September 2013
- journal article
- research article
- Published by Taylor & Francis in Epigenetics
- Vol. 8 (9) , 935-943
Abstract
Offspring exposed to gestational diabetes mellitus (GDM) have an increased risk for chronic diseases, and one promising mechanism for fetal metabolic programming is epigenetics. Therefore, we postulated that GDM exposure impacts the offspring’s methylome and used an epigenomic approach to explore this hypothesis. Placenta and cord blood samples were obtained from 44 newborns, including 30 exposed to GDM. Women were recruited at first trimester of pregnancy and followed until delivery. GDM was assessed after a 75-g oral glucose tolerance test at 24–28 weeks of pregnancy. DNA methylation was measured at > 485,000 CpG sites (Infinium HumanMethylation450 BeadChips). Ingenuity Pathway Analysis was conducted to identify metabolic pathways epigenetically affected by GDM. Our results showed that 3,271 and 3,758 genes in placenta and cord blood, respectively, were potentially differentially methylated between samples exposed or not to GDM (p-values down to 1 × 10−06; none reached the genome-wide significance levels), with more than 25% (n = 1,029) being common to both tissues. Mean DNA methylation differences between groups were 5.7 ± 3.2% and 3.4 ± 1.9% for placenta and cord blood, respectively. These genes were likely involved in the metabolic diseases pathway (up to 115 genes (11%), p-values for pathways = 1.9 × 10−13 < p < 4.0 × 10−03; including diabetes mellitus p = 4.3 × 10−11). Among the differentially methylated genes, 326 in placenta and 117 in cord blood were also associated with newborn weight. Our results therefore suggest that GDM has epigenetic effects on genes preferentially involved in the metabolic diseases pathway, with consequences on fetal growth and development, and provide supportive evidence that DNA methylation is involved in fetal metabolic programming.Keywords
This publication has 41 references indexed in Scilit:
- Insulin-Like Growth Factor 2/H19 Methylation at Birth and Risk of Overweight and Obesity in ChildrenThe Journal of Pediatrics, 2012
- Obesity and Severe Obesity Forecasts Through 2030American Journal of Preventive Medicine, 2012
- Placental Adiponectin Gene DNA Methylation Levels Are Associated With Mothers’ Blood Glucose ConcentrationDiabetes, 2012
- DNA methylation differences at growth related genes correlate with birth weight: a molecular signature linked to developmental origins of adult disease?BMC Medical Genomics, 2012
- Gestational diabetes and pregnancy outcomes - a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteriaBMC Pregnancy and Childbirth, 2012
- DNA Methylation Patterns in Cord Blood DNA and Body Size in ChildhoodPLOS ONE, 2012
- Maternal Weight Gain in Women Who Develop Gestational Diabetes MellitusObstetrics & Gynecology, 2012
- Maternal diabetes and perinatal programmingEarly Human Development, 2011
- Epigenetic Gene Promoter Methylation at Birth Is Associated With Child’s Later AdiposityDiabetes, 2011
- Dense Genotyping of Candidate Gene Loci Identifies Variants Associated With High-Density Lipoprotein CholesterolCirculation: Cardiovascular Genetics, 2011